Sort
21,281 grants matching “influenza”
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE
$3,551,701Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2021 · AI
Influenza Vaccine Research and Development
$3,550,000Masaru Kanekiyo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$3,547,646Walter A. Orens · Emory University · N01 · FY2017 · AI
Alaska INBRE-2: Environmental Agents and Disease
$3,547,292Jocelyn E Krebs · University Of Alaska Fairbanks · P20 · FY2010 · RR
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE
$3,539,326S. Mark Tompkins · University Of Georgia · N01 · FY2023 · AI
Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases
$3,532,876Nikolai Petrovsky · Vaxine Pty Ltd · N01 · FY2020 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$3,531,298Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2019 · AI
SUPPORT SURVEILLANCE,RESPONSE TO SEASONAL,PANDEMIC INFLUENZA IN WESTERN PACIFIC
$3,521,392Lee Chin-Kei · World Health Organization-West Pacific · U51 · FY2011 · IP
Immunosenescence Studies of Acute Radiation Exposure in Atomic Bomb Survivors
$3,520,209Kei Nakachi · Radiation Effects Research Foundation · N01 · FY2012 · AI
Lipid and Lipoprotein Metabolism in Atherosclerosis
$3,512,187Alan M Fogelman · University Of California Los Angeles · P01 · FY2007 · HL
Alaska INBRE-2: Environmental Agents and Disease
$3,509,537Jocelyn E Krebs · University Of Alaska Fairbanks · P20 · FY2012 · GM
Novel Nanoparticle Platform for the delivery of Vaccines and Adjuvants
$3,507,545Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U19 · FY2015 · AI
NIAID Centers of Excellence for Influenza Research and Response
$3,507,030Scott Hensley · University Of Pennsylvania · N01 · FY2024 · AI
Influenza and Emerging Infectious Diseases
$3,504,680Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
High resolution longitudinal immune monitoring for elucidating immune aging dynamics
$3,500,000Mark M Davis · Stanford University · P01 · FY2023 · AI
High resolution longitudinal immune monitoring for elucidating immune aging dynamics
$3,500,000Mark M Davis · Stanford University · P01 · FY2024 · AI
High resolution longitudinal immune monitoring for elucidating immune aging dynamics
$3,500,000Mark M Davis · Stanford University · P01 · FY2022 · AI
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
$3,496,853Gregory A. Poland · Mayo Clinic Rochester · U01 · FY2010 · AI
Clinical Studies of Vaccines for Pandemic Influenza
$3,490,570Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Novel cell-culture derived split influenza vaccine
$3,489,073Glaxosmithkline · UC1 · FY2004 · AI
International Observational Study to Characterize Adults Hospitalized with Complications of influenza Hospitalization Study (FLU 003 Plus) Portion of Study Expanded to Include COVID-19 Patients
$3,487,152Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE
$3,484,773Emmanuel Walter · Duke University · N01 · FY2023 · AI
Influenza and Emerging Infectious Diseases
$3,483,874Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Membrane Remodeling in Viral Infection and Viral Assembly
$3,483,111Joshua Zimmerberg · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA RESEARCH ACTIVITIES
$3,483,093Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2023 · AI